174 related articles for article (PubMed ID: 26740207)
1. Design, Synthesis and Antiproliferative Activity of Novel Benzothiazole Derivatives Conjugated with Semicarbazone Scaffold.
Bao G; Du B; Ma Y; Zhao M; Gong P; Zhai X
Med Chem; 2016; 12(5):489-98. PubMed ID: 26740207
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel 4-(2-fluorophenoxy)-2-(1H-tetrazol-1-yl)pyridines bearing semicarbazone moieties as potent antitumor agents.
Qin M; Liao W; Xu C; Fu B; Ren J; Gu Y; Gong P
Arch Pharm (Weinheim); 2013 Nov; 346(11):840-50. PubMed ID: 24114959
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents.
Yao J; He Z; Chen J; Sun W; Fang H; Xu W
Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967
[TBL] [Abstract][Full Text] [Related]
4. [Design, synthesis and activities of novel benzothiazole derivatives containing arylpiperazine].
Liu WH; Chang JX; Liu Y; Luo JW; Zhang JW
Yao Xue Xue Bao; 2013 Aug; 48(8):1259-65. PubMed ID: 24187833
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
Zhai X; Bao G; Wang L; Cheng M; Zhao M; Zhao S; Zhou H; Gong P
Bioorg Med Chem; 2016 Mar; 24(6):1331-45. PubMed ID: 26897090
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of benzothiazole derivatives bearing the ortho-hydroxy-N-acylhydrazone moiety as potent antitumor agents.
Ma J; Zhang G; Han X; Bao G; Wang L; Zhai X; Gong P
Arch Pharm (Weinheim); 2014 Dec; 347(12):936-49. PubMed ID: 25230149
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a Nanomolar Multikinase Inhibitor (KST016366): A New Benzothiazole Derivative with Remarkable Broad-Spectrum Antiproliferative Activity.
El-Damasy AK; Cho NC; Nam G; Pae AN; Keum G
ChemMedChem; 2016 Aug; 11(15):1587-95. PubMed ID: 27405013
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and in vitro cytotoxic activities of sorafenib derivatives].
Wang K; Li Y; Zhang LJ; Yang HZ; Chen XG; Feng ZQ
Yao Xue Xue Bao; 2014 May; 49(5):639-43. PubMed ID: 25151734
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antitumor activities of novel benzyl urea analogues of sorafenib.
Lu CS; Tang K; Li Y; Jin B; Yin DL; Ma C; Chen XG; Huang HH
Yao Xue Xue Bao; 2013 May; 48(5):709-17. PubMed ID: 23888694
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activity of (E)-2-benzothiazole hydrazones.
Lindgren EB; de Brito MA; Vasconcelos TR; de Moraes MO; Montenegro RC; Yoneda JD; Leal KZ
Eur J Med Chem; 2014 Oct; 86():12-6. PubMed ID: 25147145
[TBL] [Abstract][Full Text] [Related]
11. [Design, synthesis and antitumor activity of sorafenib analogues containing 2-picolinylhydrazide moiety].
Qin AF; Li Y; Song HR; Chen XG; Jin XF; Wang K; Zhang LJ; Huo LC; Feng ZQ
Yao Xue Xue Bao; 2012 Dec; 47(12):1623-9. PubMed ID: 23460968
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold.
Wang M; Xu S; Lei H; Wang C; Xiao Z; Jia S; Zhi J; Zheng P; Zhu W
Bioorg Med Chem; 2017 Oct; 25(20):5754-5763. PubMed ID: 28927801
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents.
Liu Z; Wu S; Wang Y; Li R; Wang J; Wang L; Zhao Y; Gong P
Eur J Med Chem; 2014 Nov; 87():782-93. PubMed ID: 25440879
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biological evaluation and preliminary mechanism study of novel benzothiazole derivatives bearing indole-based moiety as potent antitumor agents.
Ma J; Bao G; Wang L; Li W; Xu B; Du B; Lv J; Zhai X; Gong P
Eur J Med Chem; 2015; 96():173-86. PubMed ID: 25874341
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and antitumor activity of 5-substituted-2-(pyridyl)benzothiazole compounds].
Liu WH; Chang JX; Liu Y
Yao Xue Xue Bao; 2013 Jan; 48(1):83-8. PubMed ID: 23600146
[TBL] [Abstract][Full Text] [Related]
16. Diarylureas and diarylamides with pyrrolo[2,3-d]pyrimidine scaffold as broad-spectrum anticancer agents.
El-Gamal MI; Oh CH
Chem Pharm Bull (Tokyo); 2014; 62(1):25-34. PubMed ID: 24390490
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and structure-activity relationships of novel benzothiazole derivatives bearing the ortho-hydroxy N-carbamoylhydrazone moiety as potent antitumor agents.
Ma J; Chen D; Lu K; Wang L; Han X; Zhao Y; Gong P
Eur J Med Chem; 2014 Oct; 86():257-69. PubMed ID: 25171780
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents.
Abdelgawad MA; Bakr RB; Omar HA
Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160
[TBL] [Abstract][Full Text] [Related]
20. Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities.
Fahmy HH; Khalifa NM; Ismail MM; El-Sahrawy HM; Nossier ES
Molecules; 2016 Feb; 21(3):271. PubMed ID: 26927048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
